AllPennyStocks.com Big Mid-Week Move From This Small Biotech
AllPennyStocks.com

Big Mid-Week Move From This Small Biotech

Big Mid-Week Move From This Small Biotech By: Dylan Sikes – AllPennyStocks.com News

Wednesday, February 5, 2025

A Florida-based biotech company found quite a bit of mid-week success after it said that an external safety review committee recommended that its Phase 1 clinical trial of PAS-004 in advanced cancer should proceed to cohort 5, 22mg capsule, without modification. According to the release, “the biotechnology company said that this recommendation was based on the review of the safety data from three patients in cohort 4A, 15mg capsule, and the absence of any dose limiting toxicities.”

Traders wasted no time snatching up shares of Pasithea Therapeutics Corp. (Nasdaq:KTTA), pushing the micro cap to close the session up at $2.74/share (+31.73%).

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.


Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Highest-Grade Interval Since Prospect Discovery Has Investors Eyeing These Junior Miners
 Read More
Shares Of Tech Stock Surging On Breakthrough Hydrogen Technology News
 Read More
Recently-Listed Micro Cap Pops On Contract Announcement
 Read More
Most Popular
1
Shares Of Small-Cap Company Perk Higher On New Cannabis Cultivation License
2
Micro Cap Secures $1.4 Million Contract With Canadian Federal Government
3
Shares Of Tech Stock Surging On Breakthrough Hydrogen Technology News
4
This Utilities Stock Roofed On $175M Project Investment
5
Alberta, New Brunswick securities regulators warn of suspected crypto investment scam with fake news articles
6
Trump declines to rule out recession amid tariffs’ effects on markets - The Washington Post


Back to Top
Site Links:
Premium Services / Email Newsletter:
Social Media:
RSS Feed:
Partners:
© Copyright 2025 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.
© Copyright 1999 – 2025. AllPennyStocks.com Media Inc.
All rights reserved.